COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

(2021) Barliz Waissengrin et al.   LANCET ONCOLOGY

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

(2021) Leticia Monin et al.   LANCET ONCOLOGY

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective

(2020) K. de Joode et al.   EUROPEAN JOURNAL OF CANCER

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

(2020) Irina Tsibulak et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

COVID-19 in patients with cancer: managing a pandemic within a pandemic

(2020) Leora Horn et al.   Nature Reviews Clinical Oncology

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

(2020) Evan J. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccination in the elderly: The challenge of immune changes with aging

(2018) Annalisa Ciabattini et al.   SEMINARS IN IMMUNOLOGY

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

(2016) Bhumsuk Keam et al.   CANCER